Does IRBESARTAN Cause Electrocardiogram qt prolonged? 94 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Electrocardiogram qt prolonged have been filed in association with IRBESARTAN (Irbesartan). This represents 0.9% of all adverse event reports for IRBESARTAN.
94
Reports of Electrocardiogram qt prolonged with IRBESARTAN
0.9%
of all IRBESARTAN reports
2
Deaths
39
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From IRBESARTAN?
Of the 94 reports, 2 (2.1%) resulted in death, 39 (41.5%) required hospitalization, and 37 (39.4%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which IRBESARTAN Alternatives Have Lower Electrocardiogram qt prolonged Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE